|
Ping An Healthcare and Technology Company Limited (1833.hk) Valation DCF
CN | Healthcare | Medical - Healthcare Information Services | HKSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Ping An Healthcare and Technology Company Limited (1833.HK) Bundle
Améliorez vos stratégies d'investissement avec la calculatrice DCF (1833HK)! Utilisez des données financières authentiques de Ping A Healthcare and Technology Company Limited, ajustez les projections et dépenses de croissance et observez comment les modifications affectent la valeur intrinsèque de (1833HK) en temps réel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,410.2 | 7,333.3 | 7,833.4 | 6,579.0 | 4,991.6 | 5,019.4 | 5,047.3 | 5,075.4 | 5,103.6 | 5,132.0 |
| Revenue Growth, % | 0 | 35.55 | 6.82 | -16.01 | -24.13 | 0.55618 | 0.55618 | 0.55618 | 0.55618 | 0.55618 |
| EBITDA | -1,073.8 | -646.4 | -1,882.6 | -1,089.6 | -175.4 | -730.5 | -734.6 | -738.7 | -742.8 | -746.9 |
| EBITDA, % | -19.85 | -8.81 | -24.03 | -16.56 | -3.51 | -14.55 | -14.55 | -14.55 | -14.55 | -14.55 |
| Depreciation | 155.6 | 181.3 | 221.0 | 203.1 | 171.7 | 147.6 | 148.4 | 149.2 | 150.0 | 150.9 |
| Depreciation, % | 2.88 | 2.47 | 2.82 | 3.09 | 3.44 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
| EBIT | -1,229.4 | -827.7 | -2,103.6 | -1,292.8 | -347.1 | -878.1 | -883.0 | -887.9 | -892.8 | -897.8 |
| EBIT, % | -22.72 | -11.29 | -26.85 | -19.65 | -6.95 | -17.49 | -17.49 | -17.49 | -17.49 | -17.49 |
| Total Cash | 7,924.1 | 14,452.8 | 10,829.4 | 10,826.4 | 12,192.0 | 5,019.4 | 5,047.3 | 5,075.4 | 5,103.6 | 5,132.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 844.3 | 1,239.2 | 1,747.1 | 1,819.5 | 1,441.5 | 1,117.7 | 1,123.9 | 1,130.2 | 1,136.5 | 1,142.8 |
| Account Receivables, % | 15.61 | 16.9 | 22.3 | 27.66 | 28.88 | 22.27 | 22.27 | 22.27 | 22.27 | 22.27 |
| Inventories | 79.9 | 171.4 | 425.2 | 262.8 | 212.1 | 175.5 | 176.5 | 177.5 | 178.5 | 179.5 |
| Inventories, % | 1.48 | 2.34 | 5.43 | 3.99 | 4.25 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 |
| Accounts Payable | 423.0 | 544.0 | 1,213.2 | 861.4 | 949.3 | 630.8 | 634.3 | 637.8 | 641.4 | 644.9 |
| Accounts Payable, % | 7.82 | 7.42 | 15.49 | 13.09 | 19.02 | 12.57 | 12.57 | 12.57 | 12.57 | 12.57 |
| Capital Expenditure | -142.1 | -78.1 | -95.2 | -36.8 | -45.9 | -64.1 | -64.5 | -64.8 | -65.2 | -65.5 |
| Capital Expenditure, % | -2.63 | -1.07 | -1.22 | -0.55906 | -0.91921 | -1.28 | -1.28 | -1.28 | -1.28 | -1.28 |
| Tax Rate, % | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 |
| EBITAT | -1,228.9 | -834.0 | -2,123.7 | -1,292.5 | -337.4 | -873.1 | -877.9 | -882.8 | -887.7 | -892.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1,716.5 | -1,096.2 | -2,090.5 | -1,388.0 | 305.1 | -747.8 | -797.7 | -802.1 | -806.6 | -811.1 |
| WACC, % | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3,202.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -827 | |||||||||
| Terminal Value | -15,114 | |||||||||
| Present Terminal Value | -10,541 | |||||||||
| Enterprise Value | -13,743 | |||||||||
| Net Debt | -1,894 | |||||||||
| Equity Value | -11,850 | |||||||||
| Diluted Shares Outstanding, MM | 1,080 | |||||||||
| Equity Value Per Share | -10.97 |
What You Will Receive
- Authentic Ping An Data: Preloaded financials — encompassing revenue to EBIT — based on both actual and forecasted figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on Ping An's fair value.
- Flexible Excel Template: Designed for quick edits, scenario analysis, and thorough projections.
- Time-Efficient and Precise: Eliminate the need to create models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation frameworks.
- WACC Calculator: Pre-structured Weighted Average Cost of Capital model with adjustable inputs.
- Customizable Forecast Assumptions: Adjust growth projections, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Ping An Healthcare and Technology Company Limited (1833HK).
- Dashboard and Visualizations: Visual representations provide a summary of essential valuation metrics for straightforward analysis.
How It Works
- Download: Obtain the ready-to-use Excel file featuring Ping An Healthcare and Technology Company Limited’s (1833HK) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare the results.
- Make Decisions: Leverage the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for Ping An Healthcare and Technology Company Limited (1833HK)?
- Designed for Experts: A sophisticated tool favored by financial analysts, CFOs, and consultants.
- Current Data Insights: Preloaded financial information for Ping An Healthcare ensures accurate results.
- Flexible Scenario Analysis: Easily test various forecasts and assumptions to assess different outcomes.
- Comprehensive Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Experience: Step-by-step guidance simplifies the calculation process.
Who Should Utilize This Product?
- Investors: Accurately assess the fair value of Ping An Healthcare and Technology Company Limited (1833HK) before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial analysis and reporting related to Ping An Healthcare and Technology Company Limited (1833HK).
- Consultants: Easily customize the template for valuation reports tailored to clients involving Ping An Healthcare and Technology Company Limited (1833HK).
- Entrepreneurs: Discover insights into financial modeling practices employed by leading firms, including Ping An Healthcare and Technology Company Limited (1833HK).
- Educators: Employ this resource as a teaching aid to illustrate various valuation methodologies using Ping An Healthcare and Technology Company Limited (1833HK).
Contents of the Template
- Historical Data: Offers insights into Ping An Healthcare and Technology Company Limited's (1833HK) previous financial performance and baseline predictions.
- DCF and Levered DCF Models: Comprehensive templates to assess the intrinsic value of Ping An Healthcare and Technology Company Limited (1833HK).
- WACC Sheet: Pre-established calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust essential drivers such as growth rates, EBITDA percentages, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough analysis of Ping An Healthcare and Technology Company Limited's (1833HK) financials.
- Interactive Dashboard: Dynamically visualize valuation outcomes and forecasts.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.